Hypothesis

The core circadian clock drives daily oscillations in mitochondrial α‑ketoglutarate (α‑KG) production, which rhythmically fuels KDM6 demethylase activity. This creates a temporal gate on H3K27me3 removal at bivalent promoters, enforcing a protective epigenetic rhythm that counters age‑associated H3K27me3 gain and inflammaging. Loss of circadian α‑KG flux disrupts this gate, leading to unresolved bivalent domains, ectopic H3K27me3/H3K4me3 imbalance, and accelerated epigenetic aging.

Mechanistic Basis

• Circadian transcription factors CLOCK/BMAL1 regulate expression of mitochondrial enzymes such as glutaminase (GLS) and oxoglutarate dehydrogenase (OGDH), shaping α‑KG availability across the day [1].
• α‑KG is an essential co‑factor for KDM6 (KDM6A/B) demethylases; its rhythmic rise and fall directly modulates enzyme velocity in vivo.
• KDM6 activity removes H3K27me3 from bivalent promoters, allowing periodic H3K4me3‑driven transcription of genes involved in DNA repair, antioxidant response, and senescence suppression.
• When the α‑KG trough coincides with the repressive phase of the clock, transient H3K27me3 accumulation is permitted, preserving the bivalent state; during the α‑KG peak, demethylation restores balance.
• Chronic circadian disruption flattens α‑KG oscillations, causing persistently low KDM6 activity, progressive H3K27me3 accumulation at bivalent domains, and concomitant loss of H3K4me3, mirroring the epigenomic drift described in aging tissues [4].

Predictions & Experimental Tests

1. Metabolite Rhythm – Measure hepatic and neuronal α‑KG levels every 4 h over 24 h in wild‑type mice; expect a robust ∼2‑fold oscillation aligned with CLOCK/BMAL1 binding to GLS/OGDH promoters.
2. KDM6 Activity Correlation – Perform in‑vitro demethylase assays using nuclear extracts matched to α‑KG peaks/troughs; activity should mirror metabolite rhythm.
3. Chromatin Rhythm – Conduct ChIP‑seq for H3K27me3 and H3K4me3 at bivalent promoters across the circadian cycle; predict anti‑phase oscillation (high H3K27me3 at α‑KG trough, low at peak).
4. Genetic Disruption – Liver‑specific Bmal1 knockout mice should lose α‑KG oscillations, show dampened KDM6 activity, and exhibit accelerated H3K27me3 gain at bivalent loci compared with controls.
5. Rescue Experiment – Supplement Bmal1‑deficient mice with cell‑permeable α‑KG ester (dimethyl‑α‑KG) timed to the subjective day; predict restoration of H3K27me3 rhythm and attenuation of age‑related transcriptional noise.
6. Cancer Context – In KDM6‑dependent persister cancer models, timed α‑KG depletion (via GLS inhibitor) during the repressive clock phase should enhance H3K27me3 persistence and reduce persister formation, testing the firewall’s dual role.

Potential Caveats

• Tissue‑specific differences in mitochondrial flux may uncouple α‑KG rhythms from the core clock; measuring multiple organs is essential.
• α‑KG also regulates TET DNA demethylases; observed H3K27me3 changes could be secondary to DNA methylation shifts.
• Pharmacological α‑KG supplementation may affect NADH/NAD⁺ redox state, confounding interpretation; control experiments with inert analogs are required.

If validated, this hypothesis would reposition the circadian clock from a passive timer to an active metabolic gatekeeper that licenses epigenetic enzymes, offering a mechanistic link between temporal coherence and epigenomic fidelity.